House com­mit­tee plans hear­ing on Chi­nese biotech com­pe­ti­tion as ten­sions mount

The House’s Se­lect Com­mit­tee on the Chi­nese Com­mu­nist Par­ty is meet­ing next week in Boston to dis­cuss Chi­nese com­pe­ti­tion in biotech and na­tion­al se­cu­ri­ty.

The hear­ing comes weeks af­ter a draft bill in­tro­duced by Com­mit­tee Chair Mike Gal­lagher (R-WI) and oth­ers sin­gled out sev­er­al Chi­nese biotechs as “com­pa­nies of con­cern.” The leg­is­la­tion would ban fed­er­al­ly fund­ed providers from do­ing busi­ness with Chi­nese com­pa­nies, in­clud­ing WuXi AppTec and the ge­nomics gi­ant BGI Group. A sim­i­lar bill with bi­par­ti­san back­ing has been in­tro­duced in the Sen­ate.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA